Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

In Vitro Toxicology Testing Market by Products & Services, Toxicity Endpoints & Tests, Technology, Method & Industry - Forecast to 2022 - Research and Markets

Research and Markets
Posted on: 03 Oct 17

The "In Vitro Toxicology Testing Market by Products (Assays) & Services, Toxicity Endpoints & Tests (ADME, Skin, Genotoxicity, Organ Toxicity), Technology, Method (Cellular Assays, Ex-Vivo), Industry (Pharmaceutical, Cosmetics) - Forecast to 2022" report has been added to Research and Markets' offering.

The In vitro toxicology testing market is projected to reach USD 8.74 Billion by 2022 from USD 6.34 Billion in 2017, at a CAGR of 6.6%.

The key factors driving the growth of this market include opposition to animal testing, growing demand for in vitro technology in the European market, new and promising technologies, and increasing R&D expenditure to detect toxicity at an early stage. On the other hand, failure to establish intricacies of in vivo conditions through in vitro, lack of in vitro models to study complex endpoints, and a dearth of skilled professionals are the major factors restraining the growth of this market.

The US is expected to hold the largest share of the global in vitro toxicology testing market in 2017, while China is expected to witness the highest growth during 2017 to 2022. Growing R&D investments in the biopharmaceutical sector, coupled with the rising number of CROs in this country contribute to the growth of this market in China. Additionally, rising international pressure on Chinese cosmetics industry to ban animal testing is expected to further drive this market.

Companies Mentioned

  • Ascendance Biotechnology, Inc.
  • Bio-Rad Laboratories, Inc.
  • Catalent, Inc.
  • Charles River Laboratories International, Inc.
  • Covance, Inc. (A Part of Laboratory Corporation of America Holdings)
  • Cyprotex Plc (A Subsidiary of Evotec Ag)
  • Eurofins Scientific Se
  • Ge Healthcare
  • Gentronix Limited
  • MB Research Laboratories
  • Merck Kgaa
  • Promega Corporation
  • Qiagen N.V.
  • SGS S.A.
  • Thermo Fisher Scientific

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Industry Insights

6 Market Overview

7 In Vitro Toxicology Testing Market, By Product And Service

8 In Vitro Toxicology Testing Market, By Toxicity Endpoints And Tests

9 In Vitro Toxicology Testing Market, By Technology

10 In Vitro Toxicology Testing Market, By Industry

11 In Vitro Toxicology Testing Market, By Method

12 In Vitro Toxicology Testing Market, By Region

13 Competitive Landscape

14 Company Profiles

For more information about this report visit https://www.researchandmarkets.com/research/4rzlxg/in_vitro

View source version on businesswire.com: http://www.businesswire.com/news/home/20171003006005/en/

Business Wire
www.businesswire.com

Last updated on: 03/10/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.